New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn:
”Latest publication from the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital.
Highlights the variability in solid-phase antiphospholipid antibody (aPL) test results on different testing platforms.
Also highlights the decreasing use of ELISA-based procedures, and the disconnection between classification criteria for antiphospholipid syndrome (APS), as used for research, versus diagnostic criteria (see also here).
The latest publication is available for free download for the next 50 days using this link.”
Title: A contemporary analysis of solid-phase antiphospholipid antibody testing: implications for classification or diagnosis of antiphospholipid syndrome
Authors: Caitlin Thirunavukarasu, Leonardo Pasalic, Emmanuel J. Favaloro
Stay updated with Hemostasis Today.
-
Feb 2, 2026, 17:54Danny Gaskin: Nominations are Open for the BBTS Transfusion Practitioner Special Interest Group Award 2026
-
Feb 2, 2026, 17:44Important Webinar on Care for Patients with iTTP – ISTH
-
Feb 2, 2026, 17:21Tagreed Alkaltham: Some Risks Don’t Look Like Risks in Healthcare
-
Feb 2, 2026, 17:16Sifat Jubaira: Effect of Prolonged Tourniquet Application
-
Feb 2, 2026, 17:14Vivek Mahto: Understanding Deep Vein Thrombosis – Causes, Symptoms, and Prevention
-
Feb 2, 2026, 17:08Tareq Abadl: Heparin vs Warfarin
-
Feb 2, 2026, 17:07Mary Cushman: New Research on Aspirin Use in Pregnancy and Stroke Risk in Offspring
-
Feb 2, 2026, 16:52Aravind Palraj: Young Stroke is Never Just Stroke
-
Feb 2, 2026, 16:48Seyed Mohsen Jahromi Moghadam: Antithrombotic Therapy After Transcatheter Structural Heart Interventions